குழு ஆஃப் நோவர்த்திச் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from குழு ஆஃப் நோவர்த்திச். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In குழு ஆஃப் நோவர்த்திச் Today - Breaking & Trending Today

Novartis appoints Rob Kowalski as Chief People & Organization Officer


Share:
Basel, June 28, 2021 Novartis announced today the appointment of Rob Kowalski, Pharm.D., Global Head Regulatory Affairs and US Head of Drug Development as Chief People & Organization Officer. He will report to Vas Narasimhan, M.D., CEO of Novartis and become a member of the Executive Committee of Novartis (ECN), effective September 1, 2021.
Steven Baert, currently Chief People & Organization Officer, will step down from the Executive Committee of Novartis, effective June 30, 2021 after 15 years with the company and almost 8 years in position. Vicki Rawlinson, US Head People & Organization will lead the function ad-interim until Dr. Kowalski takes over.
Dr. Kowalski is a senior drug development and regulatory executive with over 25 years of industry experience. He has successfully built and led Global Regulatory Affairs, a large organization within the Novartis Drug Development with many interfaces into our commercial and R&D organizations on global and local l ....

United States , Richard Jarvis , Isabella Zinck , Thomas Hungerbuehler , Samir Shah , Julie Masow , Vicki Rawlinson , Sloan Simpson , Rob Kowalski , Steven Baert , People Organization , Global Head Regulatory Affairs , Novartis Drug Development , Us Head People Organization , Novartis Strategy Financial Communications , Bachelor Of Pharmaceutical Sciences , Exchange Commission , University Of Wisconsin , Us Head Of Drug Development , People Organization Officer , Global Regulatory Affairs , Committee Of Novartis , Drug Development , Chief People , Vas Narasimhan , Executive Committee ,

Novartis Pharma AG: Novartis appoints Rob Kowalski as Chief People & Organization Officer


Novartis Pharma AG: Novartis appoints Rob Kowalski as Chief People & Organization Officer
Basel, June 28, 2021 - Novartis announced today the appointment of Rob Kowalski, Pharm.D., Global Head Regulatory Affairs and US Head of Drug Development as Chief People & Organization Officer. He will report to Vas Narasimhan, M.D., CEO of Novartis and become a member of the Executive Committee of Novartis (ECN), effective September 1, 2021.
Steven Baert, currently Chief People & Organization Officer, will step down from the Executive Committee of Novartis, effective June 30, 2021 after 15 years with the company and almost 8 years in position. Vicki Rawlinson, US Head People & Organization will lead the function ad-interim until Dr. Kowalski takes over. ....

United States , Richard Jarvis , Isabella Zinck , Thomas Hungerbuehler , Samir Shah , Julie Masow , Vicki Rawlinson , Sloan Simpson , Rob Kowalski , Steven Baert , People Organization , Global Head Regulatory Affairs , Novartis Drug Development , Us Head People Organization , Novartis Strategy Financial Communications , Bachelor Of Pharmaceutical Sciences , Exchange Commission , University Of Wisconsin , Us Head Of Drug Development , People Organization Officer , Global Regulatory Affairs , Committee Of Novartis , Drug Development , Chief People , Vas Narasimhan , Executive Committee ,

Novartis Chief Legal Officer Shannon Klinger To Step Down, Names Thomas Kendris CLO Ad Interim


Novartis Chief Legal Officer Shannon Klinger To Step Down, Names Thomas Kendris CLO Ad Interim
BASEL (dpa-AFX) - Novartis AG (NVS) announced Friday that Shannon Thyme Klinger, Chief Legal Officer, has decided to resign from the role and return to the US to take an executive role at a biotechnology company. Klinger will step down from the Executive Committee of Novartis or ECN, effective March 15.
The company appointed Thomas Kendris, currently Global Head Litigation and US Country President, as Chief Legal Officer ad interim and attendee to the ECN in this capacity.
Kendris holds 25 years of experience across Novartis businesses. He was Novartis US Country Head of Legal, Vice President and General Counsel of US Pharma at Novartis Pharmaceuticals Corp., as well as Global General Counsel for Novartis Oncology and for Novartis Vaccines and Diagnostics. ....

Thomas Kendris , Us Pharma At Novartis Pharmaceuticals Corp , Committee Of Novartis , Shannon Thyme Klinger , Chief Legal Officer , Executive Committee , Global Head Litigation , Vice President , General Counsel , Novartis Pharmaceuticals Corp , Global General Counsel , Novartis Oncology , Novartis Vaccines , Chief Legal , எங்களுக்கு பார்மா இல் நோவர்த்திச் மருந்துகள் கார்ப் , குழு ஆஃப் நோவர்த்திச் , ஶ்யாநந் வறட்சியான தைம் கிளிங்கர் , தலைமை சட்டப்பூர்வமானது அதிகாரி , நிர்வாகி குழு , உலகளாவிய தலை வழக்கு , துணை ப்ரெஸிடெஂட் , ஜநரல் ஆலோசனை , நோவர்த்திச் மருந்துகள் கார்ப் , உலகளாவிய ஜநரல் ஆலோசனை , நோவர்த்திச் புற்றுநோயியல் , நோவர்த்திச் தடுப்பு மருந்துகள் ,